| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |